Loading...
XSWXGALE
Market cap4.07bUSD
Dec 20, Last price  
72.90CHF
1D
0.14%
1Q
0.55%
IPO
69.53%
Name

Galenica AG

Chart & Performance

D1W1MN
XSWX:GALE chart
P/E
20.93
P/S
0.97
EPS
3.48
Div Yield, %
3.04%
Shrs. gr., 5y
0.29%
Rev. gr., 5y
3.39%
Revenues
3.75b
-6.68%
2,826,272,0002,914,917,0003,008,851,0003,145,400,0003,171,342,0003,306,237,0003,479,753,0003,834,679,0004,014,348,0003,746,011,000
Net income
174m
+5.13%
81,824,00081,122,00083,393,000118,804,000147,546,000124,992,000172,245,000167,680,000165,132,000173,598,000
CFO
226m
-4.71%
84,118,000132,435,000156,818,000144,399,000173,550,000250,438,000224,360,000333,095,000236,873,000225,710,000
Dividend
Apr 12, 20242.2 CHF/sh
Earnings
Mar 11, 2025

Profile

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
URL
https://www.galenica.com/
IPO date
Apr 07, 2017
Employees
7,673
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
3,746,011
-6.68%
4,014,348
4.69%
3,834,679
10.20%
Cost of revenue
3,470,668
3,779,887
3,614,861
Unusual Expense (Income)
NOPBT
275,343
234,461
219,818
NOPBT Margin
7.35%
5.84%
5.73%
Operating Taxes
29,245
33,767
34,850
Tax Rate
10.62%
14.40%
15.85%
NOPAT
246,098
200,694
184,968
Net income
173,598
5.13%
165,132
-1.52%
167,680
-2.65%
Dividends
(110,266)
(104,443)
(89,204)
Dividend yield
3.04%
2.78%
2.62%
Proceeds from repurchase of equity
(6,063)
4,348
3,859
BB yield
0.17%
-0.12%
-0.11%
Debt
Debt current
50,484
268,637
92,769
Long-term debt
421,598
417,853
579,878
Deferred revenue
183,005
173,334
Other long-term liabilities
609,230
17,008
27,277
Net debt
9,371
376,644
314,939
Cash flow
Cash from operating activities
225,710
236,873
333,095
CAPEX
(76,374)
(70,366)
(60,073)
Cash from investing activities
(124,167)
(130,621)
(88,345)
Cash from financing activities
(79,053)
(177,207)
(139,525)
FCF
283,546
156,984
412,942
Balance
Cash
116,159
93,927
164,982
Long term investments
346,552
215,919
192,726
Excess cash
275,410
109,129
165,974
Stockholders' equity
1,487,012
1,257,278
1,248,188
Invested Capital
1,993,757
1,803,472
1,738,185
ROIC
12.96%
11.33%
10.63%
ROCE
12.13%
11.65%
10.91%
EV
Common stock shares outstanding
49,895
49,804
49,632
Price
72.75
-3.71%
75.55
10.21%
68.55
16.19%
Market cap
3,629,857
-3.53%
3,762,660
10.59%
3,402,241
16.53%
EV
3,643,005
4,143,185
3,723,319
EBITDA
378,343
334,783
318,226
EV/EBITDA
9.63
12.38
11.70
Interest
15,809
5,508
5,659
Interest/NOPBT
5.74%
2.35%
2.57%